Core Scientific, Inc. (NASDAQ:CORZ – Get Free Report) insider Todd Duchene sold 10,000 shares of Core Scientific stock in a transaction that occurred on Monday, November 2nd. The shares were sold at an average price of $12.78, for a total value of $127,800.00. Following the transaction, the insider directly owned 1,123,286 shares in the company, valued at approximately $14,355,595.08. The trade was a 0.88% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.
Core Scientific Trading Down 10.8%
Shares of Core Scientific stock opened at $11.38 on Friday. The stock has a fifty day simple moving average of $15.80 and a 200 day simple moving average of $19.52. Core Scientific, Inc. has a 12-month low of $10.59 and a 12-month high of $30.46.
Core Scientific (NASDAQ:CORZ – Get Free Report) last issued its quarterly earnings data on Thursday, November 5th. The company reported $0.47 earnings per share for the quarter, beating the consensus estimate of ($0.07) by $0.54. The company had revenue of $232.87 million for the quarter, compared to the consensus estimate of $196.54 million. On average, research analysts anticipate that Core Scientific, Inc. will post -1.36 earnings per share for the current year.
Hedge Funds Weigh In On Core Scientific
Several institutional investors have recently added to or reduced their stakes in CORZ. Parallel Advisors LLC lifted its holdings in Core Scientific by 125.0% during the third quarter. Parallel Advisors LLC now owns 1,800 shares of the company’s stock valued at $29,000 after purchasing an additional 1,000 shares during the last quarter. Covestor Ltd boosted its position in Core Scientific by 75.3% during the third quarter. Covestor Ltd now owns 116,647 shares of the company’s stock worth $1,864,000 after purchasing an additional 50,100 shares during the period. Mirae Asset Global Investments Co. Ltd. purchased a new position in shares of Core Scientific in the third quarter worth about $42,000. Partners Wealth Management LLC purchased a new position in shares of Core Scientific in the third quarter worth about $317,000. Finally, CUSHING ASSET MANAGEMENT LP dba NXG INVESTMENT MANAGEMENT increased its stake in shares of Core Scientific by 5,468.6% in the third quarter. CUSHING ASSET MANAGEMENT LP dba NXG INVESTMENT MANAGEMENT now owns 389,800 shares of the company’s stock worth $6,229,000 after purchasing an additional 382,800 shares in the last quarter.
Core Scientific News Summary
Here are the key news stories impacting Core Scientific this week:
- Positive Sentiment: For the quarter ended September 2026, Core Scientific earned $0.47 per share, versus analysts’ expected loss, and generated $232.87 million in revenue, above the $196.36 million consensus. Earnings also improved from a loss of $0.46 per share a year earlier. Core Scientific surpasses Q3 earnings and revenue estimates
- Neutral Sentiment: Analyst views remain broadly favorable but varied: the average rating was “Moderate Buy,” with a reported average price target of $31.28, while individual firms’ ratings and targets ranged from bearish to bullish. MarketBeat Core Scientific coverage
- Negative Sentiment: Insider Todd Duchene sold 10,000 shares for about $127,800. The sale was a small reduction—0.88%—in his holdings, so it may weigh on sentiment but does not indicate a major change in his position. Core Scientific insider share sale
Wall Street Analyst Weigh In
A number of research analysts recently weighed in on CORZ shares. Citigroup reissued a “market outperform” rating on shares of Core Scientific in a research report on Wednesday, October 14th. Rothschild & Co Redburn initiated coverage on shares of Core Scientific in a research report on Monday, September 21st. They issued a “neutral” rating and a $16.00 price objective for the company. Capital One Financial set a $33.00 price objective on shares of Core Scientific in a research note on Thursday, July 30th. Keefe, Bruyette & Woods upgraded shares of Core Scientific from a “market perform” rating to an “outperform” rating and increased their price objective for the company from $25.00 to $28.00 in a research note on Thursday, July 30th. Finally, BTIG Research reissued a “buy” rating and set a $38.00 target price on shares of Core Scientific in a research report on Thursday, October 15th. Two analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, two have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $31.28.
Check Out Our Latest Stock Report on Core Scientific
Core Scientific Company Profile
Core Scientific, Inc is a digital infrastructure company that develops and operates data centers for high-performance computing. The company has historically focused on bitcoin mining, using specialized computing equipment and supporting infrastructure to validate transactions on the Bitcoin network. It also provides hosting and infrastructure services for other digital asset miners.
Core Scientific is expanding its business toward hosting high-performance computing and artificial intelligence workloads.
Featured Articles
- Five stocks we like better than Core Scientific
- Google’s Credit Backstop May Be TeraWulf’s Biggest Advantage
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch
- Qualcomm Beat Earnings, But Its Fastest-Growing Businesses Have a Catch
- Oil, Uranium, or Renewables? 3 Energy Plays for a Changing Market
Receive News & Ratings for Core Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
